PSA-PSPSA-PSNYSE
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank46
Year-over-Year Change
Year-over-year research & development expense growth
Latest
0.00%
↓ 100% vs avg
Percentile
P46
Within normal range
Average
8.58%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 0.00% |
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | -100.00% |
| Q3 2023 | 64.66% |
| Q2 2023 | -43.98% |
| Q1 2023 | -39.01% |
| Q4 2022 | 228.86% |
| Q3 2022 | -30.02% |
| Q2 2022 | 29.37% |
| Q1 2022 | -5.08% |
| Q4 2021 | 58.73% |
| Q3 2021 | -34.73% |
| Q2 2021 | 59.82% |
| Q1 2021 | 2.85% |
| Q4 2020 | 8.46% |
| Q3 2020 | -61.93% |
| Q2 2020 | 74.10% |
| Q1 2020 | 39.82% |
| Q4 2019 | 33.23% |
| Q3 2019 | -23.85% |
| Q2 2019 | -16.64% |
| Q1 2019 | 171.62% |
| Q4 2018 | -33.19% |
| Q3 2018 | -5.71% |
| Q2 2018 | -48.22% |
| Q1 2018 | 72.94% |
| Q4 2017 | -18.49% |
| Q3 2017 | -13.44% |
| Q2 2017 | -41.65% |
| Q1 2017 | 35.36% |
| Q4 2016 | 9.50% |
| Q3 2016 | -2.81% |
| Q2 2016 | -19.15% |
| Q1 2016 | -8.07% |